Integrin β4 as a Potential Diagnostic and Therapeutic Tumor Marker.

Biomolecules

Department of Physiology, School of Basic Medical Science, Central South University, Changsha 410013, China.

Published: August 2021

AI Article Synopsis

Article Abstract

Integrin β4 (ITGβ4) is a class of transmembrane adhesion molecules composed of hemidesmosomes (HDs). Its unique long intracellular domain provides intricate signal transduction functions. These signal transduction effects are especially prominent in tumors. Many recent studies have shown that integrin β4 is differentially expressed in various tumors, and it plays a vital role in tumor invasion, proliferation, epithelial-mesenchymal transition, and angiogenesis. Therefore, we categorize the research related to integrin β4, starting from its structure and function in tumor tissues, and provide a basic description. Based on its structure and function, we believe that integrin β4 can be used as a tumor marker. In clinical practice, it is described as a diagnostic marker for the targeted treatment of cancer and will be helpful in the clinical diagnosis and treatment of tumors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394641PMC
http://dx.doi.org/10.3390/biom11081197DOI Listing

Publication Analysis

Top Keywords

integrin β4
20
tumor marker
8
signal transduction
8
structure function
8
integrin
5
β4 potential
4
potential diagnostic
4
diagnostic therapeutic
4
tumor
4
therapeutic tumor
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!